{"id":"https://openalex.org/W2980296453","doi":"https://doi.org/10.1182/blood.v122.21.1610.1610","title":"Mass Cytometry Analysis Of Myelofibrosis and Secondary Acute Myeloid Leukemia Reveals Constitutive and Cytokine Induced Signaling Abnormalities With Differential Sensitivities To Ruxolitinib","display_name":"Mass Cytometry Analysis Of Myelofibrosis and Secondary Acute Myeloid Leukemia Reveals Constitutive and Cytokine Induced Signaling Abnormalities With Differential Sensitivities To Ruxolitinib","publication_year":2013,"publication_date":"2013-11-15","ids":{"openalex":"https://openalex.org/W2980296453","doi":"https://doi.org/10.1182/blood.v122.21.1610.1610","mag":"2980296453"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v122.21.1610.1610","doi":"https://doi.org/10.1182/blood.v122.21.1610.1610","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.1610.1610","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111084550","display_name":"Daniel A.C. Fisher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel A.C. Fisher","raw_affiliation_strings":["Division of Hematology, Washington University School of Medicine, St. Louis, MO, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Washington University School of Medicine, St. Louis, MO, USA,","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024815439","display_name":"Gregory K. Behbehani","orcid":"https://orcid.org/0000-0002-9493-3607","observed_orcids":["https://orcid.org/0000-0002-9493-3607"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory K. Behbehani","raw_affiliation_strings":["Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA, USA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033995613","display_name":"Garry P. Nolan","orcid":"https://orcid.org/0000-0002-8862-9043","observed_orcids":["https://orcid.org/0000-0002-8862-9043"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Garry P. Nolan","raw_affiliation_strings":["Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA, USA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045383208","display_name":"Sean C. Bendall","orcid":"https://orcid.org/0000-0003-1341-2453","observed_orcids":["https://orcid.org/0000-0003-1341-2453"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sean C. Bendall","raw_affiliation_strings":["Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford, CA, USA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002632381","display_name":"Stephen T. Oh","orcid":"https://orcid.org/0000-0002-8564-5400","observed_orcids":["https://orcid.org/0000-0002-8564-5400","https://orcid.org/0000-0002-7330-0106"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen T. Oh","raw_affiliation_strings":["Division of Hematology, Washington University School of Medicine, St. Louis, MO, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Washington University School of Medicine, St. Louis, MO, USA,","institution_ids":["https://openalex.org/I204465549"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5033995613","https://openalex.org/A5045383208"],"corresponding_institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.35583915,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"122","issue":"21","first_page":"1610","last_page":"1610"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myelofibrosis","display_name":"myelofibrosis","score":0.9049999713897705},{"id":"https://openalex.org/keywords/secondary-acute-myeloid-leukemia","display_name":"secondary acute myeloid leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.9729999899864197},{"id":"https://openalex.org/keywords/jak-stat-signaling","display_name":"JAK/STAT signaling","score":0.9039999842643738},{"id":"https://openalex.org/keywords/jak2-v617f-mutation","display_name":"JAK2 V617F mutation","score":0.9459999799728394},{"id":"https://openalex.org/keywords/ruxolitinib","display_name":"ruxolitinib","score":0.9739999771118164},{"id":"https://openalex.org/keywords/thrombopoietin","display_name":"thrombopoietin","score":0.8809999823570251},{"id":"https://openalex.org/keywords/granulocyte-colony-stimulating-factor","display_name":"granulocyte colony-stimulating factor","score":0.9800000190734863},{"id":"https://openalex.org/keywords/hematopoietic-stem-and-progenitor-cells","display_name":"hematopoietic stem and progenitor cells","score":0.9739999771118164},{"id":"https://openalex.org/keywords/jak1-2-inhibitor","display_name":"JAK1/2 inhibitor","score":0.5070000290870667}],"concepts":[{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.8250514268875122},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.7916265726089478},{"id":"https://openalex.org/C2778015335","wikidata":"https://www.wikidata.org/wiki/Q17051163","display_name":"Mass cytometry","level":4,"score":0.5726466774940491},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5591610074043274},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.5485081672668457},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5044311285018921},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.4955388307571411},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4663723111152649},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4573456943035126},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.4444971978664398},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.39118334650993347},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3218924403190613},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.22927206754684448},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11805576086044312},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.06943246722221375}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v122.21.1610.1610","doi":"https://doi.org/10.1182/blood.v122.21.1610.1610","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.1610.1610","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2979938941","https://openalex.org/W2979937321","https://openalex.org/W2566942178","https://openalex.org/W2567122794","https://openalex.org/W2564188479","https://openalex.org/W4386086900","https://openalex.org/W3197715944","https://openalex.org/W4410705052","https://openalex.org/W3008798470","https://openalex.org/W2908232055"],"abstract_inverted_index":{"Abstract":[0],"The":[1,66,473],"classic":[2],"myeloproliferative":[3,75,447,519],"neoplasms":[4],"(MPNs),":[5],"including":[6,52,210,286],"primary":[7],"and":[8,39,77,123,140,161,190,215,232,237,290,292,303,311,351,377,392,396,434,489,494,505,537],"secondary":[9,61],"myelofibrosis":[10],"(MF),":[11],"are":[12,80,542],"frequently":[13,381,477,484],"associated":[14,54],"with":[15,55,158,225,256,335,421,557],"the":[16,27,101,163,170,211,218,343,424,455,501,564,583],"JAK2":[17,89,425,502,527],"V617F":[18,426],"mutation":[19],"or":[20,182,369,422,524],"other":[21,114],"genetic":[22],"alterations":[23],"in":[24,36,48,73,93,120,144,321,342,348,405,487,554,559,582,588],"members":[25],"of":[26,57,69,88,96,113,127,138,166,228,260,306,367,430,444,457,500,518,526,535,578,585],"JAK-STAT":[28,34,139],"axis.":[29],"These":[30,108,278,408,513],"mutations":[31,43,53,71],"induce":[32],"hyperactivated":[33],"signaling":[35,76,115,142,235,318,341,372,387,439,448,461,467,474,520,549,580],"cell":[37,172,245,270,284],"lines":[38],"mouse":[40],"models.":[41],"Other":[42],"have":[44,90],"been":[45,106],"found":[46],"recurrently":[47],"human":[49],"MPNs,":[50,94],"however,":[51],"transformation":[56],"chronic":[58],"MPNs":[59,145],"to":[60,178,203,268,300,327,332,413,419,471,479,511],"acute":[62],"myeloid":[63,291],"leukemia":[64],"(sAML).":[65],"aggregate":[67],"effects":[68],"these":[70,128,438,571],"on":[72,100,239,273,544],"vivo":[74,451],"disease":[78],"phenotypes":[79],"not":[81,411],"yet":[82],"well":[83,195,254],"understood.":[84],"While":[85],"targeted":[86,586],"inhibitors":[87],"shown":[91],"activity":[92,528],"evidence":[95],"a":[97,134,151,226,240,322,384,445,575],"selective":[98],"effect":[99],"underlying":[102],"malignant":[103],"clone":[104],"has":[105],"lacking.":[107],"findings":[109],"suggest":[110,436,515],"that":[111,124,154,319,437,516],"dysregulation":[112,429],"molecules":[116,129,475],"may":[117,441,529,562],"be":[118,131,442,530,552],"important":[119],"MPN":[121],"pathogenesis,":[122],"therapeutic":[125],"targeting":[126,517],"could":[130],"beneficial.":[132],"Therefore,":[133],"more":[135,370],"complete":[136],"assessment":[137],"related":[141],"pathways":[143,521],"is":[146,150],"needed.":[147],"Mass":[148],"cytometry":[149,157],"novel":[152],"technology":[153],"merges":[155],"flow":[156],"mass":[159,242],"spectrometry":[160],"enables":[162],"simultaneous":[164],"measurement":[165],"30+":[167],"parameters":[168],"at":[169],"single":[171],"level.":[173],"We":[174],"utilized":[175],"this":[176],"approach":[177],"examine":[179],"bone":[180],"marrow":[181],"peripheral":[183],"blood":[184],"samples":[185,314],"from":[186,330],"four":[187],"MF":[188,310,350,488,536],"patients":[189,420,555],"five":[191,204],"sAML":[192,312,352,414,490,538],"patients,":[193],"as":[194,196,253,255],"three":[197],"normal":[198],"controls.":[199],"Cells":[200,222],"were":[201,223,298,380,410,469,481],"exposed":[202],"different":[205],"perturbation":[206],"conditions":[207],"ex":[208],"vivo,":[209,560],"cytokines":[212],"thrombopoietin":[213],"(TPO)":[214],"G-CSF,":[216],"and/or":[217,360],"JAK1/2":[219],"inhibitor":[220],"ruxolitinib.":[221,472,512],"stained":[224],"panel":[227],"18":[229],"surface":[230,275],"markers":[231],"16":[233],"intracellular":[234,308],"effectors":[236,440],"analyzed":[238,248],"CyTOF":[241],"cytometer.":[243],"Single":[244],"data":[246,266],"was":[247,346,403,507],"using":[249],"traditional":[250],"gating":[251],"strategies,":[252],"SPADE":[257],"(spanning-tree":[258],"analysis":[259],"density-normalized":[261],"events),":[262],"which":[263,561],"distills":[264],"multidimensional":[265],"down":[267],"interconnected":[269],"subsets":[271],"based":[272],"shared":[274],"marker":[276],"expression.":[277],"methods":[279],"grouped":[280],"cells":[281],"into":[282],"distinct":[283],"populations":[285],"hematopoietic":[287],"stem/progenitors":[288],"(HSPCs)":[289],"lymphoid":[293],"lineage":[294],"subsets.":[295],"Heat":[296],"maps":[297],"constructed":[299],"depict":[301],"basal":[302,339,375,400,466],"induced":[304],"activation":[305],"each":[307],"marker.":[309],"patient":[313],"exhibited":[315,356],"abnormal":[316,338],"cytokine-induced":[317],"varied":[320],"patient-specific":[323],"manner.":[324],"HSPC":[325,344],"responses":[326,566],"TPO":[328],"ranged":[329],"hyposensitive":[331],"hypersensitive":[333,459],"compared":[334],"normal.":[336],"Markedly":[337],"(unstimulated)":[340],"compartment":[345],"observed":[347,382,404,458,567],"all":[349,406],"patients.":[353,407,539],"Each":[354],"sample":[355],"increased":[357],"total":[358,431,495],"IkB\u03b1":[359],"pCREB,":[361],"typically":[362],"accompanied":[363],"by":[364,390],"elevated":[365,486],"phosphorylation":[366,402,499],"one":[368],"additional":[371],"molecules.":[373],"Both":[374],"elevation":[376],"cytokine":[378],"hypersensitivity":[379],"within":[383],"MAP":[385],"kinase":[386],"axis":[388],"represented":[389],"pERK":[391],"downstream":[393,523],"targets":[394],"pCREB":[395,493],"pS6.":[397],"Conversely,":[398],"repressed":[399],"STAT1":[401],"abnormalities":[409,550],"exclusive":[412],"versus":[415],"MF,":[416],"nor":[417],"specific":[418],"without":[423],"mutation.":[427],"Widespread":[428],"IkB\u03b1,":[432],"pERK-pCREB-pS6,":[433],"pSTAT1":[435],"characteristic":[443],"general":[446],"phenotype.":[449],"Ex":[450],"ruxolitinib":[452,480,558],"effectively":[453],"inhibited":[454],"majority":[456],"cytokine-stimulated":[460],"effects.":[462],"In":[463,497],"contrast,":[464,498],"most":[465,476,483],"elevations":[468],"insensitive":[470,478],"those":[482],"basally":[485],"HSPC,":[491],"namely":[492],"IkB\u03b1.":[496],"substrates":[503],"STAT3":[504],"STAT5":[506],"almost":[508],"always":[509],"sensitive":[510],"results":[514],"either":[522],"independent":[525],"valuable":[531],"for":[532],"improved":[533],"treatment":[534],"Ongoing":[540],"experiments":[541],"focused":[543],"determining":[545],"whether":[546],"constitutive":[547],"ruxolitinib-insensitive":[548],"can":[551],"identified":[553],"treated":[556],"underlie":[563],"incomplete":[565],"clinically.":[568],"Taken":[569],"together,":[570],"approaches":[572],"will":[573],"provide":[574],"deeper":[576],"understanding":[577],"altered":[579],"networks":[581],"context":[584],"therapies":[587],"MPNs.":[589],"Disclosures:":[590],"Oh:":[591],"Incyte:":[592],"Consultancy,":[593],"Research":[594],"Funding,":[595],"Speakers":[596],"Bureau.":[597]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-10-18T00:00:00"}